raining
raining with http://www.mdnewscast.net

raining

Medical Newscast

News for 31-Jan-26

Source: MedicineNet High Blood Pressure General
Normal Blood Pressure in Clinic May Mask Hypertension

Source: MedicineNet Diabetes General
FDA OKs High-Tech Diabetes Device to Help Replace Fingerstick Tests

Source: MedicineNet Diabetes General
Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Source: MedicineNet High Blood Pressure General
Omega-3s a Recipe for Healthy Blood Pressure in Young Adults

Source: MedicineNet High Blood Pressure General
High Blood Pressure Rates Have Doubled Worldwide Since 1975

Source: MedicineNet High Blood Pressure General
Yoga Called Good Medicine for High Blood Pressure

Source: MedicineNet Diabetes General
Standing or 'Easy' Walks May Help Type 2 Diabetics Control Blood Sugar

Source: MedicineNet High Blood Pressure General
High Blood Pressure Might Affect Some Kids' Thinking Ability

Source: MedicineNet High Blood Pressure General
Study Finds Worrisome Heart Effects Among Some Football Players

Source: MedicineNet High Blood Pressure General
More Research Cites Salt's Potential Health Risks

Search the Web
raining
electrician
entrainement
instructors
ntc
vocational
apprenticeship
ciw
kieser
ots

The Best raining website

All the raining information you need to know about is right here. Presented and researched by http://www.mdnewscast.net. We've searched the information super highway far and wide to provide you with the best raining site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
raining.

raining

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

With billions of web pages online, you could spend a lifetime surfing the Web for raining, following links from one page to another. Amusing perhaps, but not very efficient if you are after some specific raining information. One of the biggest complaints we hear concerns the difficulty of finding targeted information. Where do you start? Searching the Internet requires part skill, part luck and a little bit of art. Fortunately, we are here to help with the hunt.

You've probably heard of search engines such as Yahoo!, Google, and AltaVista. There are literally dozens of these tools to help you locate the raining information you're looking for. The trick is understanding how they work, so you can use the right tool for the job and if the returned list of raining sites is useable. We've done this and our summary below will save you hours and hours of time.

raining

Medical Newscast
For information about Medical Newscasts look no further. We have links to great resources regarding all forms of medical internet broadcasting.
Medical Newscast

Rarely is raining information completely neutral; usually there's a point of view, maybe even a hidden agenda. Because it's so easy to publish on the Internet, opinions on raining abound. Always consider the source of the information. A website fully devoted to wireless laptop modem is more likely to be reliable than one that covers lots of disparate fields. We do recommend at the end of the day that you check out the information for yourself. You are often the very best of judges.

Why is this important? The Internet abounds with all sorts of information on raining, but unless you can be reasonably sure of its source and accuracy, be wary. For example, information about raining posted in Internet newsgroups can be flawed. Even if the raining document contains great technical detail, there is often no hard evidence to back up the claims. Don't make the mistake of accepting gossip as truth, which may prove to be professionally and financially embarrassing.

a Cold; Starve a Tumor

 by: ARA Content

(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.

At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.

The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.

Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.

One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.

Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.

If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.

About The Author

Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

Google

http://www.medmeet.com/
Go Antiques | Medical Meetings | Internet Meetings | medical mailings | Take It Right

medical mailings   Medical Meetings   Affordable Used Cars